ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,914,419 | +17.4% | 416,178 | +64.9% | 0.00% | – |
| Q2 2023 | $1,630,762 | -93.6% | 252,440 | -92.6% | 0.00% | -100.0% |
| Q1 2023 | $25,559,130 | -61.4% | 3,389,805 | -48.2% | 0.00% | -50.0% |
| Q4 2022 | $66,237,780 | +108.6% | 6,538,774 | +103.6% | 0.00% | 0.0% |
| Q3 2022 | $31,755,000 | -6.7% | 3,210,819 | +0.5% | 0.00% | 0.0% |
| Q2 2022 | $34,019,000 | +1197.0% | 3,194,309 | +1087.3% | 0.00% | – |
| Q1 2022 | $2,623,000 | +2.3% | 269,030 | +50.1% | 0.00% | – |
| Q4 2021 | $2,563,000 | +1.1% | 179,207 | +41.7% | 0.00% | – |
| Q3 2021 | $2,534,000 | – | 126,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |